Cannabis 2.0 and Big Alcohol’s $4 Billion Bet Changed Everything
Published November 15, 2019 — By Ann Karim, Senior Cannabis Editor
- Canada’s Cannabis 2.0 regulations took effect October 2019, legalizing cannabis beverages, edibles, and extracts for the first time
- Constellation Brands (Corona beer) had invested $4 billion in Canopy Growth in 2018, triggering the beverages race
- Molson Coors formed a joint venture (Truss Beverage Co.) with HEXO Corp to compete in the space
- Nanoemulsion technology — enabling faster onset times of 15-30 minutes — became the key technical battleground
- Analysts projected a $1-2 billion North American cannabis beverages market by 2025
- Early reality was more modest: the Canadian market generated roughly $15 million in 2020 as beverages launched
Why Big Alcohol Saw Cannabis Beverages as an Existential Threat
The alcohol industry had been watching cannabis legalization with growing alarm for years. Survey data consistently showed that cannabis consumers and moderate alcohol drinkers overlapped heavily, and that in legal states, some consumers were substituting cannabis for alcohol on social occasions. When Constellation Brands — the third-largest beer company in the United States — made its blockbuster $4 billion investment in Canopy Growth in August 2018, the industry’s public posture shifted from defensive to offensive.
Molson Coors followed in 2018, forming Truss Beverage Co. as a joint venture with HEXO Corp to develop cannabis drinks for the Canadian market. Anheuser-Busch InBev partnered with Tilray for non-alcoholic cannabis beverages. Lagunitas Brewing, already part of Heineken’s portfolio, launched Hi-Fi Hops — a cannabis sparkling water — in California under a separate structure that skirted federal alcohol regulations. The message from Big Alcohol was clear: cannabis beverages were real, they were coming, and legacy beer companies intended to own the category.
For cannabis consumers interested in how different product formats affect the effects they experience, beverages represented a genuinely new consumption modality. The onset, duration, and dose-control properties of well-formulated cannabis beverages differ meaningfully from smoked or vaped flower, edibles, and tinctures. Strain profiles become less relevant when cannabinoids are delivered via nanoemulsion — the terpene and cannabinoid ratios of the source material matter more than varietal identity.
“Cannabis beverages are the next frontier — a way to bring cannabis to consumers who will never smoke and who want a social drink with a predictable, controllable experience.” — cannabis industry analyst, 2019
The Technology Race: Nanoemulsion and Fast-Acting Formulations
The central technical problem for cannabis beverages was onset time. THC dissolved in oil — the traditional approach for edibles and tinctures — does not mix with water and absorbs slowly and unpredictably through the digestive system. Traditional edibles can take 30-90 minutes to produce noticeable effects, making dose titration difficult and often leading consumers to over-consume while waiting.
Nanoemulsion technology addressed this by breaking THC and other cannabinoids into microscopic droplets, typically 20-100 nanometers in diameter, that could be suspended in water and absorbed far more rapidly. Companies including Calyx Peaks, Vertosa, and Trait Biosciences competed to develop the most effective nanoemulsion systems. The target was beverages with onset times of 15-30 minutes — fast enough to function socially like alcohol, enabling consumers to calibrate their intake in real time.
For medical cannabis patients, fast-acting beverages offered specific advantages: more predictable dosing for pain or anxiety management, no smoke inhalation, and a consumption format compatible with public social situations. The terpene content of cannabis beverages became an interesting formulation question, as some manufacturers incorporated terpenes alongside cannabinoids to preserve the entourage effect that many consumers and researchers believed contributed to the therapeutic value of whole-plant cannabis products.
Canada’s Cannabis 2.0: The Real-World Launch
Canada’s Cannabis 2.0 regulations took effect October 17, 2019 — exactly one year after the original legalization date. Licensed cannabis companies could now produce and sell beverages, edibles, extracts, and topicals legally for the first time. The rollout was deliberately cautious: licensed producers had to submit product notifications to Health Canada 60 days before launching, meaning the first cannabis beverages did not appear on retail shelves until December 2019 at the earliest.
Early Canadian cannabis beverage sales were modest but growing. The category generated roughly $15 million in sales during 2020, its first full year of availability — a small fraction of total cannabis sales but a meaningful proof of concept. Consumer feedback was generally positive on format and convenience, less positive on price: cannabis beverages typically cost $5-8 per can in Canadian legal stores, competing against $2-3 illicit market alternatives and $1-2 alcoholic beers.
For dispensaries in legal US states, the Canadian launch provided a real-world reference point. California and Colorado had allowed cannabis-infused beverages since their respective legalizations, but the category had remained niche due to regulatory complexity and formulation challenges. The Canada 2.0 data encouraged US brands to invest more aggressively in beverages as a growth category through 2020 and beyond.
The Market Reality vs. the Hype: What 2019 Actually Delivered
The 2019 cannabis beverages story was ultimately a tale of enormous anticipation against modest early reality. The investments were real, the companies were serious, and the technology was advancing — but consumer adoption moved more slowly than analysts had projected. Many consumers remained loyal to flower and traditional edibles. Beverages occupied significant retail shelf space relative to their sales contribution, creating merchandising challenges for dispensary operators.
The format also faced regulatory obstacles. US state rules on cannabis beverages varied dramatically: some states prohibited beverages exceeding certain THC concentrations; others required packaging that was indistinguishable from non-intoxicating drinks, raising concerns about accidental consumption. Cannabis law at the state level had not been written with sophisticated beverage products in mind, and updating those regulations was a slow process in most jurisdictions.
The long-term trajectory remained clearly positive. As formulations improved, prices came down, and regulations became clearer, cannabis beverages established a growing foothold in the legal market. The alcohol industry’s major investments validated the category as a strategic priority. For curious consumers wondering how cannabis beverages compare to other formats in terms of effects and onset, the category had matured enough by 2020 to offer reliable options at several price points.